Idiopathic recurrent polyneuropathy is one of several distinct syndromes involving the peripheral nervous system which share similar microscopic alterations of the interesting Schwann cell-myelin sheath of the axon collectively referred to as hypertrophic neuropathies (Austin, 1956; Byers and Taft, 1957; Thomas and Lascelles, 1967) . In all six patients with hypertrophic neuropathy studied by Thomas and Lascelles (1967) , extensive segmental demyelination was present. Moreover, this paranodal loss of myelin was seen in certain areas in the absence of any other pathological alteration, suggesting to these investigators that segmental demyelination was the initial morphological alteration in these diseases. Presumably, if this process of demyelination and subsequent remyelination continues, other characteristic alterations ensue, including shortening of the internodal lengths, as seen on longitudinal sections, and concentric cellular proliferation around individual axons with variable accumulation of 'connective tissue' in the endoneurial spaces as seen on crosssection. These reactive changes to chronic injury have been shown to be manifestations of Schwann cell proliferation (Thomas and Lascelles, 1967; Garcin, Lapresle, Fardeau, and deRecondo, 1966; Webster, Schroder, Asbury, and Adams, 1967) . Although the pathological features are similar, the stimulus to or mechanism of cellular proliferation in these various conditions may be quite different. Recently Arnason, Asbury, Astrom, and Adams (1968) have suggested experimental allergic neuritis as a possible model for acute idiopathic polyneuritis. In both these conditions segmental demyelination is a characteristic finding.
In certain of these hypertrophic neuropathies, variably referred to as recurrent polyneuropathy (Austin, 1958) , recurrent hypertrophic polyneuritis (Nattrass, 1921-22) , and chronic Guillain-Barre syndrome (Hinman and Magee, 1967) , treatment with glucocorticoids has been followed by variable degrees of improvement in the patient's condition (Austin, 1958; Hinman and Magee, 1967) . However, since Austin's detailed observations in 1958 on the steroid responsiveness of certain recurrent hypertrophic neuropathies (Austin, 1958) , little more has been added to the literature on this aspect of the subject.
This report describes a 12-year-old girl who suffered from a chronic relapsing polyneuropathy which proved to be steroid responsive. After 16 months of virtual quadriplegia and 30 months from onset, she recovered dramatically on prolonged treatment to the point of independent ambulation and has continued in remission on an alternate day programme of steroid treatment.
CASE REPORT
An 11-year-old white girl (NIH 07-66-59) was admitted to the Medical Neurology Branch for evaluation of a chronic relapsing peripheral neuropathy of three years' duration. She had been well until the age of 8. Gradually thereafter, during the autumn of 1964, bilateral weakness of ankle dorsiflexion evolved over a three month period, manifested initially by frequent stumbling and steppage gait. Later, weakness of hands and wrist extensors appeared. In November 1964, neurological examination in another hospital confirmed a generalized distal weakness of arms and legs with areflexia and slight diminution in response to pin prick over the distal extremities. The remainder of the examination was normal. Lumbar puncture results included an opening pressure of 200 mm H20, protein 134 mg and glucose 62 mg/100 ml., and a cell count of three erythrocytes and four mononuclear cells/c.mm. A diagnosis of GuillainBarre syndrome was advanced.
During the next 14 months, her condition worsened only slightly, without any periods of improvement. In late December 1965, a sudden worsening of her disease resulted in onset over a 48 hour period of virtual quadriplegia with mild dysphagia and slight dyspnoea necessitating hospitalization. Dexamethasone therapy totalling 20 mg over the subsequent month coincided with gradual 62 regression of weakness. The remission continued for three months after discontinuation of the steroid. Spinal fluid proteins of 244 mg and 200 mg/100 ml. were recorded during this four month period.
In late May 1966, the patient relapsed over a period of six weeks again to a quadriplegic state. In July 1966, dexamethasone therapy was resumed with a total dosage of 165 mg given over six weeks. Her condition again remitted slowly, coincident with steroid treatmentbut after a three to four week lag period-and continued for 21 months after discontinuation of the steroid. Admission to a second hospital at the beginning of remission in late August 1966 involved an extensive re-evaluation. Neurological findings included marked weakness of distal and proximal muscles of the arms and legs and generalized areflexia. Cross-sections of the sural nerve biopsy revealed a decrease in the number of myelinated fibres, the largest measuring 9 ,& in diameter.
Details of these findings are reported by Dyck, Gutrecht, Bastron, Kames, and Dale (1968) Gradual recovery continued until November 1966, when the patient could take a few steps with a walking aid, followed by slow exacerbation until January 1967, at which point she was bedridden and totally dependent on her parents for care. Other than facial and neck movements, she was quadriplegic in bed and remained so through her admission to the National Institutes of Health in late November 1967. Bladder and bowel function have always been normal.
When admitted the patient was a pleasant, obese young girl with prominent cushingoid features (see Fig. la ). Pupils were normally reactive and extraocular movements were full. Optic disc margins were indistinct bilaterally with some fullness of the nerve head. Spontaneous venous pulsations were present. Visual acuity Normal 24 hr urine analyses included 17-hydroxycorticosteroids 6-4 mg/24 hr, 17-ketosteroids 5.7 mg/24 hr, a-amino nitrogen 70 mg/24 hr, lead 2 usg/100 ml., mercury 1 usg/100 ml., arsenic non-detectable, coproporphyrins negative, uroporphyrins negative, porphobilinogen negative.
Seventy-two hour stool collections while on a 100 g fat diet on two occasions revealed 3 3 g and 2-8 g faecal fat/24 hr (normal less than 5 g/24 hr).
Results of lumbar puncture on each occasion were abnormal and are summarized in the Table. ELECTROMYOGRAPHY (Engel and Brooke, 1966) . In both instances the muscle was abnormal; muscle fibres varied in diameter from 8 to 55 ,u. The majority of these fibres remained round or somewhat angular with lesser numbers being truly angular. Interspersed among the atrophied fibres were several 'hypertrophied' fibres measuring 45 to 55 ,u in diameter. Histochemistry demonstrated two distinct fibre types as defined by their respective staining properties (Engel and Brooke, 1966 (Fig. 3d) .
TREATMENT The patient's clinical course and treatment are summarized in Fig. 2 RESULTS OF TREATMENT Within 48 hours of beginning prednisone and potassium chloride therapy, a very small functional improvement was observed. The patient regained the ability to roll 5 to 100 laterally in either direction while supine. There was no appreciable recovery of motor function beyond this point for the next 3j months. However, the daily vital capacity measurements reflected subtle, continual improvement from week to week. Three and a half months after prednisone was started and 1i months after chloroquine was added to the regimen, the patient clearly began recovering strength, first in her arms and hands, later in her feet and toes. In the fifth month of therapy she was able to feed herself for the first time in 16 months. Vital capacity measurements continued to improve, reaching 100 00 of predicted normal for age by the eleventh month of treatment. Her functional recovery of summated motor power from late March (fourth month) through December (thirteenth month) was virtually linear, as depicted in Fig. 2 .
At time of discharge the patient was fully independent in daily activities; she was able to rise from supine to sitting and sitting to standing without assistance and walk alone 25 to 30 ft. (7-6 m to 9 1 m) before tiring. With crutches, she would walk several hundred feet and one flight of stairs. Her hand movements showed remarkable return of function, with no contractures or deformities. Finger dexterity at time of discharge was excellent; she was able to write and sew with facility. Mild cushingoid features remained. She had clear, articulate speech and normal cranial nerve function. Sensory examination remained normal. Detailed cerebellar testing of appendicular functions failed to demonstrate any abnormality. However, stance was mildly broad based, and gait had an ataxic quality with marked unsteadiness and rapid fatigue appearing when crutches were removed. Strength was considered normal in the neck and arms and almost normal in the proximal groups of the legs. Distally, tibial and peroneal muscle groups remained moderately weak with slight foot drop bilaterally. She was able to 100\ .S 90 \"- Since discharge the patient has continued on an alternate day steroid programme for five months and has remained in remission, continuing gradually to recover additional motor function (see Fig. lb ).
DISCUSSION
The major purpose of this report is to emphasize (1) the remarkable recovery of a person with idiopathic recurrent polyneuropathy after reinstitution of glucocorticoid therapy after she had lain quadriplegic for over 13 months, and (2) the long lag period This patient illustrates the typical features of an idiopathic chronic relapsing hypertrophic polyneuropathy. Extending over four years, there were three well-documented clinical exacerbations followed by remissions. At no time since onset has the patient been completely well. However, despite periods of total inactivity extending up to 16 months, joint deformities did not develop and contractures were limited to slight heel cord shortening. Such lack of prominent contractures even after a long period of weakness is characteristic of this type of illness. On every occasion, CSF protein values were elevated; the protein electrophoresis and immunoglobulin studies on one sample (see the Table) were qualitatively normal, with quantitative increases in all fractions being the major feature. These observations coincide precisely with the immunochemical studies on CSF proteins in the Guillain-Barre syndrome reported by Ravn and Jensen (1965) and by Osuntokun, Prineas, and Field (1966) .
Pathologically, sural nerve biopsy findings showed segmental demyelination, characteristic 'onion bulb whorling' of proliferating Schwann cells and an increase in endoneurial connective tissue (Dyck, Gutrecht, Bastron, Karnes, and Dale, 1968) ; an intramuscular nerve twig showed increased endoneurial connective tissue and laminated swirls around myelinated fibres (Fig. 3d) .
Electrophysiologically, a pattern of denervation was seen on EMG; motor and sensory nerve conduction velocities were profoundly slowed, with prolonged distal latencies. Although improved, the conduction velocities remained quite slow even after remarkable clinical recovery had occurred.
The response to glucocorticoid therapy, although ultimately rewarding, was preceded by a latency period of 31 months, during which interval there was only very minimal clinical evidence suggesting recovery. The patient's first exacerbation (Fig. 2) had evolved abruptly over 48 hours after an indolent course of several months; treatment with dexamethasone in low doses (total dose of 20 mg over 30 days) was rather promptly beneficial. The second exacerbation had evolved more slowly; treatment with dexamethasone in much higher doses (total dose of 165 mg over six weeks) was followed by a latency period of three to four weeks before clinical remission became apparent. With the third exacerbation, the patient remained quadriplegic for over 13 months before prednisone treatment was begun. Although there was minimal evidence of benefit documented by weekly improvements in vital capacity measurements (Fig. 2) and subtle changes in detailed manual muscle testing, a latency period of 3i months elapsed before functional recovery could be clearly demonstrated. To generalize from this one patient, and with the assumption that the prolonged administration of oral glucocorticoids was the beneficial factor, the clinical course suggests that the latency period extending from institution of glucocorticoid therapy to the onset of clinically apparent recovery roughly correlates with the total duration of the illness and the length of the preceding exacerbation. In patients with a long exacerbation and/or total course, therapeutic efforts should be continued for at least several months before abandoning hope of recovery. In order to minimize the side effects of glucocorticoids, we include in the treatment programme generous use of antacids, potassium supplementation and a high protein isocaloric diet low in salt and carbohydrate content. Early institution of a vigorous physical therapy programme is considered to aid in off-setting some of the debilitating effects of prolonged inactivity and chronic steroid treatment, and prepare the patient for the postural changes and demands of weight bearing attendant on recovery. An active assisted range of motion exercises and tilt-table manoeuvres were particularly beneficial in this case.
The possible therapeutic benefits of intrathecal glucocorticoids, chloroquine, and supplemental vitamins given to this patient remain unclear. Because of the patient's precarious state, the high CSF protein values, and the known involvement of spinal roots as well as peripheral nerves in this type of disease (Haymaker and Kernohan, 1949) , it was elected to administer glucocorticoids by the intrathecal route as well. There is no clear evidence, however, that this route of administration hastened the rate of recovery.
Also to be emphasized is the patient's continuing remission while on alternate day steroid treatment and a simultaneous regression of her cushingoid features. In this case, and in other patients with inflammatory myopathy (DeVivo and Engel, 1969) , we have been impressed with this programme in significantly minimizing the serious side-effects of glucocorticoids, while simultaneously maintaining the underlying disease in satisfactory control. Because of the fluctuating nature of the present patient's neuropathy, more time must elapse before one can be confident of the effectiveness of an alternate day regimen in controlling this disease. However, the paucity of side-effects and the proven effectiveness of glucocorticoids in controlling other diseases considered to be immunologically mediated, together with our experience in this case, are encouraging and prompt us to recommend consideration of the alternate day glucocorticoid programme as treatment for idiopathic recurrent neuropathy until more specific therapy becomes recurrent neuropathy and produce a clinical reavailable.
mission. The basic mechanism of disease and the mode of action of the therapeutic agents in effecting remissions remains to be elucidated. Several years ago, Waksman and Adams (1955) 
